ライフサイエンスコーパス: primary immune deficiency

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 at are perturbed by single-gene mutations in primary immune deficiency.

2 fer several advantages for the correction of primary immune deficiencies.

3 he enrolled persons was 9 years, and 99% had primary immune deficiencies.

4 understanding of the molecular basis of many primary immune deficiencies.

5 leukocyte adhesion deficiency are the major primary immune deficiencies affecting phagocytic blood c

6 mportant to conceptualize the association of primary immune deficiencies and autoimmunity.

7 se for cell-based therapies for cancer, HIV, primary immune deficiencies, and autoimmune diseases, bu

8 Chronic granulomatous disease (CGD) is a primary immune deficiency characterized by a defect in r

9 ommon variable immune deficiency (CVID) is a primary immune deficiency characterized by low levels of

10 The most severe primary immune deficiency diseases (PIDs) have been succ

11 h American centers studying therapy for rare primary immune deficiency diseases (PIDs), including sev

12 Primary immune deficiency diseases arise due to heritabl

13 Persons with primary immune deficiency disorders (PIDD) who receive o

14 (PEPD), a cellular dipeptidase implicated in primary immune deficiencies in humans.

15 ciency (CVID), the most frequent symptomatic primary immune deficiency in humans, is a heterogeneous

16 ophil homeostasis using a zebrafish model of primary immune deficiency induced by the human inhibitor

17 we summarize the recent advances in treating primary immune deficiency (PID) disorders by stem cell t

18 With the burgeoning field of genetics, primary immune deficiencies (PIDs) can be diagnosed and

19 Recent studies in patients with primary immune deficiencies (PIDs) have led to important

20 al missense variants in a gene implicated in primary immune deficiency, PLCG2, and a negative regulat

21 s of donors that is used to prevent or treat primary immune deficiency, several infectious diseases,

22 tion in a range of new, genetically defined, primary immune deficiency states; and (iii) experimental

23 ts cause loss of gene function, resulting in primary immune deficiencies such as severe combined immu

24 icacy of the ongoing gene therapy trials for primary immune deficiencies, the first reports of new tr

25 The Primary Immune Deficiency Treatment Consortium (PIDTC) i

26 The Primary Immune Deficiency Treatment Consortium (PIDTC) i

27 The Primary Immune Deficiency Treatment Consortium (PIDTC) i

28 The Primary Immune Deficiency Treatment Consortium attempted

29 The Primary Immune Deficiency Treatment Consortium was forme

30 n American Society for Immunodeficiency, and Primary Immune Deficiency Treatment Consortium.

31 ur review of the literature regarding PML in primary immune deficiencies we found 26 cases, only 54%

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。